ASX: RGT
Argent Biopharma
Where Argent Biopharma sits on every Catalyst Ahead leaderboard: its share price against peers, its latest raise, how the market took its announcements and where the money traded.
Close
—
Market value
—
Boards today
1
leaderboards it is on
Best placing
—
Vs raise price
—
no recent raise
Days on boards
1
in the last 90 days
ASKResourceful — ask about Argent Biopharma
Open full Resourceful ↗
12MShare price
Daily candlesThis chart is TradingView data, delayed 15 minutes. Our own price and move columns are computed from Yahoo daily candles, so during a trading session the two can visibly disagree.
PDFMost recent investor presentation
No investor presentation from Argent Biopharma on the ASX in the last two years.
JUMPDid the jump stick?
Announcement boards"RGT Executes Global CannEpil Licensing Deal for US$5.5M" (7 July 2026) lifted shares +105.7%. By 2 Nov 2026 they were −28.6% on the day before: most of the jump has gone.
90DOn our boards
Last 90 days| Board today | Placing | Why |
|---|---|---|
| Did the jump stick? | — | +105.7% on the day, -28.6% now |
On our boards on 1 day in the last 90
- 2 Nov 2026: Did the jump stick?
▶Most recent company video
Sign in to watch the latest verified Argent Biopharma video here. It’s free.
ASXRecent announcements
All on the ASX ↗The ASX announcement list could not be read just now.